title: Trends in the use of bilateral mastectomy in England from 2002 to 2011: retrospective analysis of hospital episode statistics.
abstract: OBJECTIVE
  For healthy women at high risk of developing breast cancer, a bilateral mastectomy can reduce future risk. For women who already have unilateral breast cancer, removing the contralateral healthy breast is more difficult to justify. We examined trends in the number of women who had a bilateral mastectomy in England between 2002 and 2011.
  
  
  METHODS
  Retrospective cohort study using the Hospital Episode Statistics database.
  
  
  METHODS
  NHS hospital trusts in England.
  
  
  METHODS
  Women aged between 18 and 80 years who had a bilateral mastectomy (or a contralateral mastectomy within 24 months of unilateral mastectomy) with or without a diagnosis of breast cancer.
  
  
  METHODS
  Number and incidence of women without breast cancer who had a bilateral mastectomy; number and proportion who had a bilateral mastectomy as their first breast cancer operation, and the proportion of those undergoing bilateral mastectomy who had immediate breast reconstruction.
  
  
  RESULTS
  Among women without breast cancer, the number who had a bilateral mastectomy increased from 71 in 2002 to 255 in 2011 (annual incidence rate ratio 1.16, 95% CI 1.13 to 1.18). In women with breast cancer, the number rose from 529 to 931, an increase from 2% to 3.1% of first operations (OR for annual increase 1.07, 95% CI 1.05 to 1.08). Across both groups, rates of immediate breast reconstruction roughly doubled and reached 90% among women without breast cancer in 2011.
  
  
  CONCLUSIONS
  The number of women who had a bilateral mastectomy nearly doubled over the last decade, and more than tripled among women without breast cancer. This coincided with an increase in the use of immediate breast reconstruction.
authors.affiliation: Department of Health Services Research & Policy, London School of Hygiene & Tropical Medicine, London, UK.
authors.forename: Jenny
authors.initials: J
authors.lastname: Neuburger
authors.forename: Fiona
authors.initials: F
authors.lastname: Macneill
authors.forename: Ranjeet
authors.initials: R
authors.lastname: Jeevan
authors.forename: Jan H P
authors.initials: JH
authors.lastname: van der Meulen
authors.forename: David A
authors.initials: DA
authors.lastname: Cromwell
keywords: Oncology; Plastic & Reconstructive Surgery; Preventive Medicine
references.citation: J Clin Oncol. 2011 Apr 20;29(12):1564-9
references.pmid: 21402610
references.citation: Ann Surg Oncol. 2011 Oct;18(11):3129-36
references.pmid: 21947590
references.citation: Breast Cancer Res Treat. 2011 Oct;129(3):955-61
references.pmid: 21553118
references.citation: J Clin Oncol. 2007 Sep 20;25(27):4210-6
references.pmid: 17878475
references.citation: Ann Surg Oncol. 2010 Oct;17(10):2554-62
references.pmid: 20461470
references.citation: Cochrane Database Syst Rev. 2010 Nov 10;(11):CD002748
references.pmid: 21069671
references.citation: J Natl Cancer Inst. 2001 Nov 7;93(21):1633-7
references.pmid: 11698567
references.citation: J Clin Oncol. 2009 Mar 20;27(9):1362-7
references.pmid: 19224844
references.citation: Ann Surg Oncol. 2012 Aug;19(8):2600-6
references.pmid: 22396004
references.citation: Plast Reconstr Surg. 2013 Jan;131(1):15-23
references.pmid: 23271515
references.citation: N Engl J Med. 1999 Jan 14;340(2):77-84
references.pmid: 9887158
references.citation: Asian Pac J Cancer Prev. 2012;13(4):1413-8
references.pmid: 22799341
references.citation: J Clin Oncol. 2004 Mar 15;22(6):1055-62
references.pmid: 14981104
references.citation: Lancet Oncol. 2005 Jun;6(6):377-82
references.pmid: 15925815
references.citation: Cancer. 2009 Dec 1;115(23):5404-12
references.pmid: 19787635
references.citation: N Engl J Med. 2007 Mar 29;356(13):1295-303
references.pmid: 17392300
references.citation: J Clin Oncol. 2007 Nov 20;25(33):5203-9
references.pmid: 17954711